| Synthesis and antiviral activity of novel 1, 3, 4-thiadiazole inhibitors of DDX3X A Brai, S Ronzini, V Riva, L Botta, C Zamperini, M Borgini, CI Trivisani, ... Molecules 24 (21), 3988, 2019 | 44 | 2019 |
| DDX3X inhibitors, an effective way to overcome HIV-1 resistance targeting host proteins A Brai, V Riva, F Saladini, C Zamperini, CI Trivisani, A Garbelli, C Pennisi, ... European Journal of Medicinal Chemistry 200, 112319, 2020 | 34 | 2020 |
| Proteins from Tenebrio molitor: An interesting functional ingredient and a source of ACE inhibitory peptides A Brai, CI Trivisani, C Vagaggini, R Stella, R Angeletti, G Iovenitti, ... Food Chemistry 393, 133409, 2022 | 27 | 2022 |
| Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor A Brai, A Boccuto, M Monti, S Marchi, I Vicenti, F Saladini, CI Trivisani, ... ACS Medicinal Chemistry Letters 11 (5), 956-962, 2020 | 21 | 2020 |
| Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma E Rango, L D'Antona, G Iovenitti, A Brai, A Mancini, C Zamperini, ... European Journal of Medicinal Chemistry 223, 113653, 2021 | 13 | 2021 |
| Novel alternative ribonucleotide excision repair pathways in human cells by DDX3X and specialized DNA polymerases V Riva, A Garbelli, F Casiraghi, F Arena, CI Trivisani, A Gagliardi, L Bini, ... Nucleic Acids Research 48 (20), 11551-11565, 2020 | 11 | 2020 |
| Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses V Riva, A Garbelli, A Brai, F Casiraghi, R Fazi, CI Trivisani, A Boccuto, ... Journal of Medicinal Chemistry 63 (17), 9876-9887, 2020 | 11 | 2020 |
| Progress towards adjuvant development: focus on antiviral therapy A Brai, F Poggialini, C Pasqualini, CI Trivisani, C Vagaggini, E Dreassi International Journal of Molecular Sciences 24 (11), 9225, 2023 | 8 | 2023 |
| Efficient use of agricultural waste to naturally fortify Tenebrio molitor mealworms and evaluation of their nutraceutical properties A Brai, F Poggialini, CI Trivisani, C Vagaggini, F Tarchi, V Francardi, ... Journal of Insects as Food and Feed 9 (5), 599-610, 2023 | 8 | 2023 |
| Targeting DDX3X helicase activity with BA103 shows promising therapeutic effects in preclinical glioblastoma models A Brai, V Riva, L Clementi, L Falsitta, C Zamperini, V Sinigiani, ... Cancers 13 (21), 5569, 2021 | 8 | 2021 |
| DEAD-box helicase DDX3X as a host target against emerging viruses: New insights for medicinal chemical approaches A Brai, CI Trivisani, F Poggialini, C Pasqualini, C Vagaggini, E Dreassi Journal of Medicinal Chemistry 65 (15), 10195-10216, 2022 | 7 | 2022 |
| Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors LJI Balestri, CI Trivisani, F Orofino, D Fiorucci, GI Truglio, I D’Agostino, ... ACS Medicinal Chemistry Letters 14 (4), 417-424, 2023 | 3 | 2023 |
| Structural insights into neonicotinoids and N-unsubstituted metabolites on human NAChRs by molecular docking, dynamics simulations, and calcium imaging K Grillberger, E Cöllen, CI Trivisani, J Blum, M Leist, GF Ecker International Journal of Molecular Sciences 24 (17), 13170, 2023 | 2 | 2023 |
| Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication G Gori Savellini, G Anichini, F Manetti, CI Trivisani, MG Cusi Viruses 16 (5), 689, 2024 | | 2024 |
| APPLICATION OF COMPUTATIONAL METHODS FOR THE IDENTIFICATION OF NEW DDX3X INHIBITORS CI Trivisani Università degli Studi di Siena, 2021 | | 2021 |
| Synthesis and Antiviral Activity of Novel 1, 3, 4-Thiadiazole Inhibitors of DDX3X S Ronzini, V Riva, C Zamperini, M Borgini, CI Trivisani, A Garbelli, ... | | 2019 |
